share_log

4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Dogan Timur

4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Dogan Timur

4/A：持股变动声明(修正)-高管 Dogan Timur
美股SEC公告 ·  2024/09/23 13:29

Moomoo AI 已提取核心信息

Cardio Diagnostics Holdings, Inc. (CDIO.US) reported that its Chief Technology Officer, Dogan Timur, completed a purchase of company stock on September 6, 2024. The transaction involved the acquisition of 68,965 shares of common stock at a price of $0.29 per share. Following this transaction, Timur's direct holdings in the company increased to a total of 197,310 shares. The transaction is part of an open market or private purchase, as per the announcement.
Cardio Diagnostics Holdings, Inc. (CDIO.US) reported that its Chief Technology Officer, Dogan Timur, completed a purchase of company stock on September 6, 2024. The transaction involved the acquisition of 68,965 shares of common stock at a price of $0.29 per share. Following this transaction, Timur's direct holdings in the company increased to a total of 197,310 shares. The transaction is part of an open market or private purchase, as per the announcement.
Cardio Diagnostics Holdings, Inc.（CDIO.US）报道其首席技术官Dogan Timur于2024年9月6日完成了公司股票的购买。 该交易涉及以每股0.29美元的价格收购68,965股普通股。 在此交易之后，Timur在公司的直接持股增加到总共197,310股。 根据公告，该交易是公开市场或私人购买的一部分。
Cardio Diagnostics Holdings, Inc.（CDIO.US）报道其首席技术官Dogan Timur于2024年9月6日完成了公司股票的购买。 该交易涉及以每股0.29美元的价格收购68,965股普通股。 在此交易之后，Timur在公司的直接持股增加到总共197,310股。 根据公告，该交易是公开市场或私人购买的一部分。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    热议
    美股
    股票代码最新价涨跌幅

    暂无数据

    资讯热榜
    更新时间